These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hypophysiotrophic function of vasopressin and oxytocin. Antoni FA; Kovács KJ; Dohanits J; Makara GB; Holmes MC; Mazurek MF Brain Res Bull; 1988 Jun; 20(6):729-36. PubMed ID: 3409054 [TBL] [Abstract][Full Text] [Related]
4. Different signaling molecules responsible for IL-1beta-induced oxytocinergic and vasopressinergic neuron activation in the hypothalamic paraventricular nucleus of the rat. Wang X; Zhang XJ; Tan QR; Ju G; Wang BR Neurochem Int; 2006 Mar; 48(4):312-7. PubMed ID: 16386822 [TBL] [Abstract][Full Text] [Related]
5. Distributions of pro-vasopressin expressing and pro-vasopressin deficient CRH neurons in the paraventricular hypothalamic nucleus of colchicine-treated normal and adrenalectomized rats. Whitnall MH J Comp Neurol; 1988 Sep; 275(1):13-28. PubMed ID: 3262632 [TBL] [Abstract][Full Text] [Related]
6. Neuropeptide cells and fibers in the hypothalamus and pituitary of the fetal sheep: comparison of oxytocin and arginine vasopressin. Hoffman GE; McDonald T; Figueroa JP; Nathanielsz PW Neuroendocrinology; 1989 Dec; 50(6):633-43. PubMed ID: 2515463 [TBL] [Abstract][Full Text] [Related]
8. Intensive venous sampling of adrenocorticotropic hormone in rats with sham or paraventricular nucleus lesions. Boyle LL; Brownfield MS; Lent SJ; Goodman B; Vo-Hill H; Litwin J; Carnes M J Endocrinol; 1997 Apr; 153(1):159-67. PubMed ID: 9135580 [TBL] [Abstract][Full Text] [Related]
9. Effect of paraventricular lesions on corticotropin-releasing factor (CRF)-like immunoreactivity in the stalk-median eminence: studies on the adrenocorticotropin response to ether stress and exogenous CRF. Bruhn TO; Plotsky PM; Vale WW Endocrinology; 1984 Jan; 114(1):57-62. PubMed ID: 6317350 [TBL] [Abstract][Full Text] [Related]
10. Neurohypophyseal peptides in aging and Alzheimer's disease. Ishunina TA; Swaab DF Ageing Res Rev; 2002 Jun; 1(3):537-58. PubMed ID: 12067600 [TBL] [Abstract][Full Text] [Related]
11. Potentiation of vasopressin analgesia in rats treated neonatally with monosodium glutamate. Bodnar RJ; Truesdell LS; Nilaver G Peptides; 1985; 6(4):621-6. PubMed ID: 4070021 [TBL] [Abstract][Full Text] [Related]
12. Effect of chronic hyponatremia on central and peripheral oxytocin and vasopressin secretion in rats. Iványi T; Dohanics J; Verbalis JG Neuroendocrinology; 1995 Apr; 61(4):412-20. PubMed ID: 7783854 [TBL] [Abstract][Full Text] [Related]
13. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations. Herman JP; Wiegand SJ; Watson SJ Endocrinology; 1990 Nov; 127(5):2408-17. PubMed ID: 2171915 [TBL] [Abstract][Full Text] [Related]
14. Olfactory bulbectomy increases vasopressin, but not corticotropin-releasing hormone, content in the external layer of the median eminence of male rats. Marcilhac A; Anglade G; Hery F; Siaud P Neurosci Lett; 1999 Mar; 262(2):89-92. PubMed ID: 10203238 [TBL] [Abstract][Full Text] [Related]
15. Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy. Plotsky PM; Sawchenko PE Endocrinology; 1987 Apr; 120(4):1361-9. PubMed ID: 3030697 [TBL] [Abstract][Full Text] [Related]
16. Developmental changes of nitric oxide synthase expression in the rat hypothalamoneurohypophyseal system. Yuan Q; Scott DE; So KF; Wu W Anat Rec A Discov Mol Cell Evol Biol; 2006 Jan; 288(1):36-45. PubMed ID: 16342209 [TBL] [Abstract][Full Text] [Related]
17. Effect of oestrogen-dependent vasopressin on HPA axis in the median eminence of female rats. Nishimura K; Yoshino K; Sanada K; Beppu H; Akiyama Y; Nishimura H; Tanaka K; Sonoda S; Ueno H; Yoshimura M; Maruyama T; Ozawa H; Ueta Y Sci Rep; 2019 Mar; 9(1):5153. PubMed ID: 30914732 [TBL] [Abstract][Full Text] [Related]
18. Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei. Ogilvie KM; Lee S; Rivier C Brain Res; 1997 Jan; 744(1):83-95. PubMed ID: 9030416 [TBL] [Abstract][Full Text] [Related]
19. Effects of lesions in the paraventricular nucleus of the hypothalamus on vasopressin and oxytocin contents in brainstem and spinal cord of rat. Lang RE; Heil J; Ganten D; Hermann K; Rascher W; Unger T Brain Res; 1983 Feb; 260(2):326-9. PubMed ID: 6831205 [TBL] [Abstract][Full Text] [Related]
20. Through the central V2, not V1 receptors influencing the endogenous opiate peptide system, arginine vasopressin, not oxytocin in the hypothalamic paraventricular nucleus involves in the antinociception in the rat. Yang J; Chen JM; Song CY; Liu WY; Wang G; Wang CH; Lin BC Brain Res; 2006 Jan; 1069(1):127-38. PubMed ID: 16409991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]